158 related articles for article (PubMed ID: 32026099)
1. The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast Carcinoma.
Pu Q; Lu L; Dong K; Geng WW; Lv YR; Gao HD
J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):37-50. PubMed ID: 32026099
[TBL] [Abstract][Full Text] [Related]
2. CREB3L4 promotes angiogenesis and tumor progression in gastric cancer through regulating VEGFA expression.
Wang N; Chen Y; Shi C; Lin Z; Xie H
Cancer Gene Ther; 2022 Feb; 29(2):241-252. PubMed ID: 33637885
[TBL] [Abstract][Full Text] [Related]
3. Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.
Aljohani AI; Joseph C; Kurozumi S; Mohammed OJ; Miligy IM; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jun; 181(3):541-551. PubMed ID: 32350677
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
Jing X; Liang H; Hao C; Yang X; Cui X
Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
[TBL] [Abstract][Full Text] [Related]
5. PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.
Wang H; He Z; Xia L; Zhang W; Xu L; Yue X; Ru X; Xu Y
Oncol Rep; 2018 Oct; 40(4):2343-2352. PubMed ID: 30066880
[TBL] [Abstract][Full Text] [Related]
6. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
7. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
[TBL] [Abstract][Full Text] [Related]
8. The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer.
El Ansari R; Alfarsi L; Craze ML; Masisi BK; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2020 May; 181(1):1-12. PubMed ID: 32200487
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
10. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
Liu D
Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
[TBL] [Abstract][Full Text] [Related]
11. Identification of Creb3l4 as an essential negative regulator of adipogenesis.
Kim TH; Jo SH; Choi H; Park JM; Kim MY; Nojima H; Kim JW; Ahn YH
Cell Death Dis; 2014 Nov; 5(11):e1527. PubMed ID: 25412305
[TBL] [Abstract][Full Text] [Related]
12. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
14. The role of CREB3L4 in the proliferation of prostate cancer cells.
Kim TH; Park JM; Kim MY; Ahn YH
Sci Rep; 2017 Mar; 7():45300. PubMed ID: 28338058
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer.
Kurozumi S; Yamaguchi Y; Hayashi S; Hiyoshi H; Suda T; Gohno T; Matsumoto H; Takei H; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
Cancer Med; 2016 Aug; 5(8):1873-82. PubMed ID: 27334118
[TBL] [Abstract][Full Text] [Related]
16. Taxotere-induced WNT16 Expression in Carcinoma-Associated Fibroblasts Might Associate with Progression and Chemoresistance of Breast Cancer.
Xiang L; Song Z; Rong G
Ann Clin Lab Sci; 2020 Mar; 50(2):205-212. PubMed ID: 32366558
[TBL] [Abstract][Full Text] [Related]
17. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
18. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
20. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.
Wang S; Li W; Liu N; Zhang F; Liu H; Liu F; Liu J; Zhang T; Niu Y
J Cell Biochem; 2012 Jun; 113(6):1904-14. PubMed ID: 22234886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]